Evotec SE American Depositary Shares (EVO)

About EVO

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Website

www.evotec.com/

Fundamentals

Market cap

$693.72M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-1.09

Dividend yield

—

Beta

2.05

Avg. volume

—

Evotec SE American Depositary Shares Competitors

Chosen by industry and closest market cap.

• EVO

  Evotec SE American Depositary Shares

  $1.91

  ▼ 2.80%
  Market cap $693.72MP/E —
  $3.18$7.3
• NGNE

  Neurogene Inc. Common Stock

  $36.38

  ▼ 3.91%
  Market cap $680.52MP/E —
  $15.93$43.66
• CTMX

  CytomX Therapeutics Inc. Common Stock

  $3.22

  ▼ 5.99%
  Market cap $733.66MP/E —
  $1.9$8.21
• CYRX

  CryoPort Inc. Common Stock

  $16.08

  ▼ 2.96%
  Market cap $741.42MP/E —
  $7.61$17.2
• PHAR

  Pharming Group N.V. ADS each representing 10 ordinary shares

  $11.7

  ▼ 0.68%
  Market cap $766.28MP/E 88.15
  $0.8338$1.82
• CBIO

  Crescent Biopharma Inc. Common Stock

  $17.74

  ▼ 0.14%
  Market cap $610.27MP/E —
  $8.72$27.41
• MPLT

  MapLight Therapeutics Inc. Common Stock

  $12.64

  ▲ 0.80%
  Market cap $602.19MP/E —
  $9.1$40.43

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Evotec Q2 EPS $(0.15) Misses $(0.06) Estimate, Sales $166.802M Miss $212.370M Estimate
  Benzinga · 8/13/2026
• Evotec Affirms FY2026 Sales Guidance of $667.470M-$714.310M vs $673.750M Est
  Benzinga · 8/13/2026
• Odyssey Taps Evotec's AI-Driven Discovery Platform To Advance Autoimmune, Inflammatory Disease Programs
  Benzinga · 8/6/2026

Institutional Ownership

March 31, 2026

Total shares held

8.15M

Total value held

$20.19M

Institutional holders

45